Zhang, Hong-Qi <br/><br/>
Taxifolin Inhibits Receptor Activator of NF-κB Ligand-Induced Osteoclastogenesis of Human Bone Marrow-Derived Macrophages in vitro and Prevents Lipopolysaccharide-Induced Bone Loss in vivo.  [electronic resource] 

 -  Pharmacology  2019 
 - 101-109 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1423-0313 
<br/><br/><label>Standard No.: </label>10.1159/000495254  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Actins--metabolism<br/>Animals<br/>Bone Resorption--chemically induced<br/>Cathepsin K--metabolism<br/>Cell Differentiation--drug effects<br/>Disease Models, Animal<br/>Humans<br/>I-kappa B Kinase--metabolism<br/>Lipopolysaccharides--pharmacology<br/>Macrophages--cytology<br/>Male<br/>Matrix Metalloproteinase 9--metabolism<br/>Mice<br/>Mice, Inbred C57BL<br/>NF-kappa B--genetics<br/>NFATC Transcription Factors--metabolism<br/>Osteogenesis--drug effects<br/>Osteolysis--chemically induced<br/>Quercetin--analogs & derivatives<br/>RANK Ligand--antagonists & inhibitors<br/>RAW 264.7 Cells<br/>Signal Transduction<br/>Transcription Factor RelA--metabolism